Programs

Cancer

Autoimmune

Disease Target To Be Defined

Antibody

Antibody

Small Molecule

Small Molecule

Discovery

Preclinical

IND Enabling

Clinical

GIM-122 (First-in-class)

Dual-functioning

GIM-531 (First-in-class)

Treg Inhibitor

GIM-407 (First-in-class)

Treg Activator

GIM-616 (First-in-class)

Undisclosed

GIM-710 (First-in-class)

Undisclosed

GIM-0915 (First-in-class)

Undisclosed

GIM-0228 (First-in-class)

Undisclosed

GIM-1213s

Several Targets